La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Sonic Healthcare Gestion

Gestion contrôle des critères 3/4

Le PDG Sonic Healthcare's est Colin Goldschmidt, nommé en Jan1993, a un mandat de 31.58 ans. La rémunération annuelle totale est A$ 5.97M, composée du salaire de 39.7% et des bonus 60.3%, y compris les actions et options de la société. détient directement 0.21% des actions de la société, d'une valeur de A$ 27.30M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 27.6 ans et 9.8 ans.

Informations clés

Colin Goldschmidt

Directeur général

AU$6.0m

Rémunération totale

Pourcentage du salaire du PDG	39.7%
Durée du mandat du directeur général	31.7yrs
Propriété du PDG	0.2%
Durée moyenne d'occupation des postes de direction	27.7yrs
Durée moyenne du mandat des membres du conseil d'administration	9.9yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Colin Goldschmidt a-t-elle évolué par rapport aux bénéfices de Sonic Healthcare?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	AU$511m
Mar 31 2024	n/a	n/a	AU$508m
Dec 31 2023	n/a	n/a	AU$505m
Sep 30 2023	n/a	n/a	AU$595m
Jun 30 2023	AU$6m	AU$2m	AU$685m
Mar 31 2023	n/a	n/a	AU$850m
Dec 31 2022	n/a	n/a	AU$1b
Sep 30 2022	n/a	n/a	AU$1b
Jun 30 2022	AU$8m	AU$2m	AU$1b
Mar 31 2022	n/a	n/a	AU$1b
Dec 31 2021	n/a	n/a	AU$1b
Sep 30 2021	n/a	n/a	AU$1b
Jun 30 2021	AU$7m	AU$2m	AU$1b
Mar 31 2021	n/a	n/a	AU$1b
Dec 31 2020	n/a	n/a	AU$951m
Sep 30 2020	n/a	n/a	AU$739m
Jun 30 2020	AU$4m	AU$2m	AU$528m
Mar 31 2020	n/a	n/a	AU$554m
Dec 31 2019	n/a	n/a	AU$581m
Sep 30 2019	n/a	n/a	AU$565m
Jun 30 2019	AU$6m	AU$2m	AU$550m
Mar 31 2019	n/a	n/a	AU$510m
Dec 31 2018	n/a	n/a	AU$470m
Sep 30 2018	n/a	n/a	AU$473m
Jun 30 2018	AU$5m	AU$2m	AU$476m

Rémunération vs marché: La rémunération totale de Colin ($USD 4.02M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Australian ($USD 2.64M ).

Rémunération et revenus: La rémunération de Colin a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Colin Goldschmidt (70 yo)

31.7yrs

Titularisation

AU$5,968,507

Compensation

Dr. Colin Stephen Goldschmidt, M.B.B.Ch., F.R.C.P.A., F.A.I.C.D. serves as the Chief Executive Officer of Sonic Healthcare Limited since 1993 and has been its Managing Director since 1992. Dr. Goldschmidt...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Colin Goldschmidt	CEO, MD & Executive Director	31.7yrs	AU$5.97m	0.21% A$ 26.5m
Christopher Wilks	Finance Director	31.7yrs	AU$2.84m	0.13% A$ 16.7m
Peter Savage	Chief Business Officer	no data	pas de données	pas de données
Stephen Fairy	Global Chief Medical Officer	no data	pas de données	pas de données
David Byrne	Chief Executive Officer of The Doctors Laboratory	no data	AU$1.07m	pas de données
Paul Alexander	Deputy CFO & Company Secretary	23.7yrs	AU$354.42k	pas de données
Julian Adler	Chief Executive Officer of Sonic Imaging	4.3yrs	pas de données	pas de données
Prashan Kulasekera	Assistant Company Secretary	no data	pas de données	pas de données

27.7yrs

Durée moyenne de l'emploi

65yo

Âge moyen

Gestion expérimentée: L'équipe de direction de SHL est chevronnée et expérimentée (ancienneté moyenne 27.6 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Colin Goldschmidt	CEO, MD & Executive Director	31.7yrs	AU$5.97m	0.21% A$ 26.5m
Christopher Wilks	Finance Director	34.8yrs	AU$2.84m	0.13% A$ 16.7m
Kathryn Spargo	Non-Executive Independent Director	14.2yrs	AU$263.00k	0.0054% A$ 693.4k
Christine Bennett	Independent Non-Executive Director	2yrs	AU$153.79k	0.0011% A$ 135.9k
Neville Mitchell	Independent Non-Executive Director	7yrs	AU$266.00k	0.0020% A$ 260.2k
Mark Compton	Independent Non-Executive Chairman	9.9yrs	AU$550.00k	0.0030% A$ 387.1k
Louis Panaccio	Non-Executive Independent Director	19.3yrs	AU$262.00k	0.0017% A$ 214.0k
Katharine Giles	Independent Non-Executive Director	2yrs	AU$153.79k	0.00052% A$ 66.6k
Suzanne Crowe	Non-Executive Independent Director	4.4yrs	AU$230.80k	0.0015% A$ 192.2k

9.9yrs

Durée moyenne de l'emploi

67.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de SHL sont considérés comme expérimentés (ancienneté moyenne 9.8 ans).

Sonic Healthcare Gestion

Gestion contrôle des critères 3/4

Informations clés

Mises à jour récentes de la gestion

Sonic Healthcare Limited, Annual General Meeting, Nov 19, 2024

Finance Director recently sold AU$1.3m worth of stock

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Recent updates

Sonic Healthcare Limited, Annual General Meeting, Nov 19, 2024

Final dividend of AU$0.63 announced

Sonic Healthcare Limited Declares Final Dividend for the Six Months Ended 30 June 2024, Payable on 19 September 2024

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Sonic in the Running for Healius Imaging Business

New minor risk - Shareholder dilution

Upcoming dividend of AU$0.43 per share

First half dividend increased to AU$0.43

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Sonic Healthcare Limited (ASX:SHL) signed binding agreements to acquire Pathology Watch Inc. for $130 million.

Finance Director recently sold AU$1.3m worth of stock

Upcoming dividend of AU$0.62 per share at 3.2% yield

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Sonic Healthcare Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 20% undervalued after recent price drop

Sonic Healthcare Limited (ASX:SHL) signed an binding agreement to acquire synlab Suisse SA from SYNLAB International GmbH for CHF 150 million.

Upcoming dividend of AU$0.42 per share at 3.1% yield

First half 2023 earnings released

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 22, 2023

Sonic Healthcare Limited to Report First Half, 2023 Results on Feb 16, 2023

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Upcoming dividend of AU$0.60 per share

Full year 2022 earnings released: EPS: AU$3.06 (vs AU$2.76 in FY 2021)

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 September, 2022

Insufficient new directors

Upcoming dividend of AU$0.40 per share

Sonic Healthcare Limited (ASX:SHL) announces an Equity Buyback for AUD 500 million worth of its shares.

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 23, 2022

Sonic Healthcare Limited (ASX:SHL) acquired ProPath Laboratory, Inc.

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

CEO, MD & Executive Director recently sold AU$8.4m worth of stock

Upcoming dividend of AU$0.55 per share

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

Sonic Healthcare Limited (ASX:SHL) signed a binding agreement to acquire Canberra Imaging Group.

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

New 90-day low: AU$31.39

First half 2021 earnings released: EPS AU$1.42 (vs AU$0.54 in 1H 2020)

Revenue beats expectations

Sonic Healthcare Limited to Report First Half, 2021 Results on Feb 18, 2021

Sonic Healthcare Limited to Report Fiscal Year 2021 Results on Aug 18, 2021

Sonic Healthcare Limited Elects Professor Suzanne Crowe as A Director

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Earnings released

New 90-day high - AU$34.66

Sonic Healthcare Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day high - AU$33.38

New 90-day high - AU$31.60

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Équipe de direction

Durée moyenne de l'emploi

Âge moyen

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen